ALX Oncology Holdings, Inc. (ALXO)
1.98
-0.01
(-0.50%)
USD |
NASDAQ |
May 22, 16:00
1.985
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings EPS Diluted (Quarterly) : -0.1714 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| ADMA Biologics, Inc. | 0.1889 |
| Biogen, Inc. | 2.153 |
| Aldeyra Therapeutics, Inc. | -0.0572 |
| CytomX Therapeutics, Inc. | -0.1029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.93M |
| Total Expenses (Quarterly) | 17.93M |
| Enterprise Value | 139.16M |
| Earnings Yield | -75.31% |
| Normalized Earnings Yield | -73.21 |